Management Strategies of combined Severe Symptomatic Carotid & Coronary Artery Disease
Mazen Abu-Fadel, MD, Associate Professor, Department of Medicine/Cardiovascular Diseases
Upon completion of this activity, participants will be able to: Review the overall cardiovascular risk for patients with combined cardiac and carotid artery disease. To review recent data on different methods of revascularization of such patients. To introduce protocols to help treat such patients in our institution.
Disclosure Report: Course Director: Dr. C. A. Sivaram is a consultant and receives honoraria for Medtronic, Inc. Planning Committee Member: Dr. Dwight Reynolds has received grants/research support from Medtronic, Inc. and is a consultant and received honorarium from Medtronic, Inc. and Sorin. Dr. Faisal Latif has no financial relationships or affiliations to disclose. Course Contact: Kelsey Peters has no financial relationships or affiliations to disclose. Speaker Disclosure: Dr. Mazen Adu-Fadel receives honorarium from Abbott and Sanofi Aventis.
Disclaimer Statement: Statements, opinions and results of studies contained in the program are those of the presenters/authors and do not reflect the policy or position of the Board of Regents of the University of Oklahoma (“OU”) nor does OU provide any warranty as to their accuracy or reliability. Eery reasonable effort has been made to faithfully reproduce the presentations and material as submitted. However, no responsibility is assumed by OU for any claims, injury and/or damage to persons or property from any cause, including negligence or otherwise, or from any use or operation of any methods, products, instruments or ideas contained in the material herein.
For more information contact:
Department of Medicine/Cardiovascular Diseases